tiprankstipranks
Trending News
More News >
Orthocell Ltd (AU:OCC)
ASX:OCC
Australian Market

Compare Orthocell Ltd (OCC) vs. Competitors

Compare
73 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Orthocell Ltd
AU$0.92
AU$249.60M
-25.63
-37.84%
1 Buy
0 Hold
0 Sell
Moderate Buy
Paradigm Biopharmaceuticals
AU$0.33
AU$132.22M
-6.14
-45.05%
Immutep Ltd
AU$0.26
AU$582.12M
-9.36
12.86%
3 Buy
0 Hold
0 Sell
Strong Buy
Dimerix Limited
AU$0.54
AU$303.20M
-21.22
12.22%
Recce Pharmaceuticals Ltd.
AU$0.41
AU$161.94M
-6.22
23.08%
Arovella Therapeutics Limited
AU$0.08
AU$103.30M
-12.65
-54.74%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:OCC
Orthocell Ltd
0.92
-0.55
-37.41%
AU:PAR
Paradigm Biopharmaceuticals
0.31
-0.23
-42.45%
AU:IMM
Immutep Ltd
0.40
0.08
23.44%
AU:DXB
Dimerix Limited
0.51
0.07
14.77%
AU:RCE
Recce Pharmaceuticals Ltd.
0.56
0.12
27.27%
AU:ALA
Arovella Therapeutics Limited
0.09
-0.10
-54.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts